checkAd

    EQS-News  149  0 Kommentare Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase agreement with HealthCare Royalty - Seite 3


    19.03.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com

    Language: English
    Company: Heidelberg Pharma AG
    Gregor-Mendel-Str. 22
    68526 Ladenburg
    Germany
    Phone: +49 (0)89 41 31 38 - 0
    Fax: +49 (0)89 41 31 38 - 99
    E-mail: investors@hdpharma.com
    Internet: www.heidelberg-pharma.com
    ISIN: DE000A11QVV0
    WKN: A11QVV
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1861991

     
    End of News EQS News Service

    Lesen Sie auch

    1861991  19.03.2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1861991&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e
    Seite 3 von 3



    Diskutieren Sie über die enthaltenen Werte



    EQS Group AG
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von EQS Group AG
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    EQS-News Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase agreement with HealthCare Royalty - Seite 3 EQS-News: Heidelberg Pharma AG / Key word(s): Financing Heidelberg Pharma announces receipt of non-refundable upfront cash payment following the successful closing of its royalty purchase agreement with HealthCare Royalty 19.03.2024 / 09:47 …